Q2 2024 SAGE Therapeutics Inc Earnings Call Transcript
Good afternoon. Welcome to SAGE Therapeutics' second-quarter 2024 financial results conference call. (Operator Instructions) This call is being webcast live on the Investors and Media section of SAGE's website at sagerx.com.
This call is a property of SAGE Therapeutics and recording, reproduction or transmission of this call without the express written consent of SAGE Therapeutics is strictly prohibited.
Please note that this call is being recorded.
I would now like to introduce Ashley Kaplowitz, Vice President of Investor Relations and Capital Markets at SAGE.
Good afternoon, and thank you for joining SAGE Therapeutics' second-quarter 2024 financial results conference call. Before we begin, I encourage everyone to go to the Investors and Media section of our website at sagerx.com where you can find the press release and slides related to today's call.
I would like to point out that we will be making forward-looking statements, which are based on our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |